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I
n the UK, palliative care plays an
important role in supporting patients and
their carers during the course of a
progressive and life-threatening illness. There
has been much research into people’s
preferred place of care and death, the future
care needs of an aging society and the lack of
resources and services in the community to
support people’s wishes.1,2 There have also
been numerous national drivers to emphasise
and promote community-based care.
Government documents and policies3
recognise the role of flexible respite care to
maintain and sustain carers in their unsung
roles, especially as they save the healthcare
system a significant amount of money,4,5
particularly towards the end of life.6 The End of
Life Care Strategy3 emphasised care in and by
the community and avoidance of hospital
admissions whenever possible, primarily to
stick to patient preferences but also to reduce
the cost of inpatient hospital care. The 2005
National Service Framework for Long-term
Conditions stated that ‘carers have a right to
obtain the support and services they require
for the person they care for and for themselves
as carers’.7 However, respite care, which
provides support to patients (and their carers)
and helps ensure they can remain in their own
home, is a scarce resource. 
What is respite care?
The most frequently adopted definition of
respite care is that proposed by Miller as ‘the
temporary physical, emotional or social care
of a dependent person in order to provide
relief from care giving to the primary
provider’.8 This is supported by research.9–11
The beneficiary of respite care is usually
considered to be the informal carer (although
there may also be benefits for the care
recipient),12–15 as respite care decreases their
burden, promotes their well-being16–18 and
provides them with ongoing support.16,19,20
Respite services may not necessarily be a
‘discrete intervention’13 (one defined area of
care) but a range of services in a variety of
settings – day care in a centre on a weekly
basis; intermittent care in the person’s home,
which may be a few hours at weekly intervals;
or residential care in an institution, which
may be from a few days to two weeks.4,9,13,17,21 It
is vital that the correct service is identified to
provide the appropriate support.22,23
Respite care at St Joseph’s Hospice
St Joseph’s Hospice in East London has
developed a strategic plan aimed at
strengthening the existing service provision
by offering a full range of services to meet the
varying needs and expectations of all patients,
their carers and families, and to provide extra
support for carers. The hospice wanted to put
in place a facility that would allow each
patient to maintain or regain as much
independence as possible, with a
comprehensive multidisciplinary team
focused on rehabilitation working with the
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If patients’ preferred place of care is their home, then it is crucial to help carers cope with
their roles – which is what respite care should do. Diane Laverty, Sara Faithfull and Anne
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  Respite care is poorly developed despite the emphasis on allowing
patients to be cared for in their preferred place – often their home. 
  It is essential to support informal carers in continuing in their roles
by providing adequate and timely relief from their duties.
  Patients who live alone with no informal carers should also be
given the opportunity to have a change from their context of care. 
  Respite care programmes should involve specific referral criteria,
multidisciplinary triaging, predetermined admission and discharge
dates, a thorough review of the patient and their caring context,
and a structured programme of care and signposting.
Key points
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patient, their carer and family. This was an
ambitious aim that would require careful
thought relating to the appropriate use of the
hospice’s beds. The emphasis of care would
remain firmly entrenched in promoting a
patient’s self-care and control over their life,
including the patient’s and carers’/family’s
ability to cope with a life-threatening illness. It
was also acknowledged that carers need to
have time out from their caring role so that
they can maintain good health and continue
to care for the patient on an ongoing basis.
To understand respite care at the hospice,
and in view of the increasing amount of
literature, research and government
documents supporting care at home, it was
timely to review the inpatient respite care by
conducting a retrospective case review
(Phase 1). The purpose of the case review was
to examine and agree appropriate bed usage
and the feasibility of setting up a nurse-led
respite service for the local boroughs served by
the hospice. The goals were to determine what
type of patients were being referred for
‘respite’, the actual reason for admission
(determined at initial assessment), the length
of stay, their needs during their stay and the
outcome of the admission. This was followed
by a pilot study (Phase 2), which involved
establishing two additional beds in the
existing inpatient wards to begin the
development of a new respite service. 
Setting
St Joseph’s Hospice is situated in a large
deprived urban area with people coming from
diverse ethical, cultural, religious, social and
economic backgrounds. At the time, the
hospice had a 32-bed inpatient unit. There are
three community palliative care teams based
at the hospice which work across three
boroughs, and the hospice provides inpatient
care for a further six boroughs. There is also a
day hospice and an evolving outpatient
service. In addition, the local communities are
invited to utilise a non-clinical area offering
information, advice and support to manage
the impact and consequences of progressive
and life-threatening conditions.
Historically, at St Joseph’s Hospice, no beds
were specifically allocated to respite care. Beds
would be made available if they were vacant
and if there were no patients waiting to be
admitted for symptom control or terminal
care, who were considered the priority. 
Phase 1 – Case review
The details of all patients referred for ‘respite
care’ between April 2009 and March 2010 were
obtained from the PalCare data system and the
clinical notes were accessed. A proforma was
developed to capture the data required for the
case review. There were 55 patients referred 
for respite care during the study period, but 
12 sets of notes were missing, resulting in 
43 patients being reviewed. The age range was
46–97 years (mean 73 years). There was very
little difference in gender (23 male, 20 female).
The majority of patients were White British
(22 patients, 51%) and lived across six of the
nine boroughs. Thirty-four patients (79%) had
been diagnosed with malignant disease and
nine (21%) with non-malignant disease. 
The main source of referral was acute
hospital doctors (11 referrals, 25%), with GPs
and specialist hospital or community teams
also referring. Out of the 43 patients reviewed,
27 (63%) were admitted and 16 (37%) were
not, due to a variety of reasons (no bed
available, patient still undergoing active
treatment with curative intent, family
declining a hospice admission and patient not
deemed to be appropriate for admission).
Out of the 27 admitted patients, 18 (67%)
lived with a carer (13 with a spouse, three with
a daughter and two with a son) and nine
(33%) lived alone with no informal carers.
Eleven patients with informal carers had no
paid carers and four informal carers had their
own health concerns.
The length of stay ranged from one to 85
days (mean 19 days). Most patients (14, 51%)
Respite care can 
help keep informal
carers well and able 
to continue in their 
role, but can also give
patients living alone 
a break from the 
context of their usual
place of care
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were known to the hospice. On admission, 17
(63%) patients were identified as having
physical problems and two as being in the
terminal stage. A recent deterioration had
been documented in 11 (40%) of the patients. 
Some patients had a predetermined date of
discharge (13, 48%); out of these 13 patients,
three (23%) died at the hospice and 10 (77%)
were discharged. Conversely, there were 14
(52%) patients who had no predetermined
date of discharge; eight of them (57%) died,
only three (21.5%) were discharged and the
remaining three (21.5%) were transferred to
an alternative care setting as they were not
well enough to return home (see Table 1). 
When there was a social reason
documented for admission, those reasons
were: carer not coping (eight, 29%), carer in
hospital (four, 14%) and carer on holiday
(three, 11%). The actual documented reasons
for admission (determined after assessment
on admission) were: respite in 12 (44.5%)
cases, symptom control in 10 (37.5%) and
terminal care in five (18%) (see Table 2).
Phase 2 – Pilot study
In view of these findings and the recent
appointment of a nurse consultant, a pilot
study was conducted over ten months to trial
a nurse-led service for patients requiring
inpatient respite care. An additional bed on
the existing two wards in the hospice was
created and utilised for this purpose. Specific
respite care referral criteria were devised (see
Box 1). Referrals were triaged by a
multidisciplinary team and, if they were
considered appropriate, dates of admission
and discharge were determined. The patient,
carer and referrer were informed of these
dates. The patient received an information
leaflet detailing, for example, the importance
of their continued routine, what to bring with
them (medication, walking aids) and the aim
of maximising their independence and
functionality during their planned stay. 
A multidisciplinary steering group was
established to begin developing plans for this
new service, in conjunction with the ongoing
development of an operational policy.
According to an analysis of data from the
first seven months of the pilot study, 24
patients were admitted for 29 episodes of care
(five patients had more than one planned
respite care admission). The majority of
patients (22) stayed for a period of two weeks.
The mean age of the 13 female patients was
65 years (range 44–76 years) and the mean age
of the 11 male patients was 73 years (range 
46–82 years). The majority of patients were
White British, which is indicative of the
general occupancy of the hospice (but not of
the local population). The referrers were
mainly the community teams (the respite
service had not been widely advertised
externally at this point). Forty-two per cent of
patients lived alone and came for a break from
the context of their care; 51% of admissions
were to give carers respite; the remaining
patients were admitted because of complex
situations requiring a review of the care at
home. Fifty-eight per cent of admitted
patients had a non-malignant diagnosis
(mainly respiratory and neurological). 
During their planned stay, most patients
required a low level of symptom control and
rehabilitative or functional interventions. Only
two had to be transferred to a medical colleague
due to a deterioration of their condition and
the need for higher-level medical intervention
(such as intravenous antibiotics for sepsis).
Most patients benefited from a wide
multidisciplinary input. No patients died. 
The respite programme involved a
comprehensive multidisciplinary admission
process (by a nurse consultant, staff grade
doctor, ward nurse and therapist), a review of
disease status and symptoms, the setting of
goals that patients would like to achieve
during their stay (review of functional status,
introduction to the day hospice programme,
and so forth) and the planning of activities
and therapies (complementary interventions,
review by a dietitian in case of poor appetite,
weight loss or taste changes, and so forth). The
day hospice and volunteers played an active
role in the programme.
Discussion
Although specific referral criteria were not
initially available, guidelines for referral and a
general description of respite care were
Table 1. Predetermined date of discharge
Predetermined date Predetermined date 
of discharge? Yes of discharge? No
13 (48%) 14 (52%)
Died 3 (23%) 8 (57%)
Discharged home 10 (77%) 3 (21.5%)
Transferred 0 3 (21.5%)
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available on the hospice’s website (the referral
criteria on the website were broad in scope,
mentioning ‘a structured approach to care’
and recommended planned admission and
discharge dates). Pressure on acute beds and a
desire to get patients out of hospital and to a
place of safety may have been foremost in
healthcare professionals’ minds when
referring patients to the hospice for respite
care, which may have resulted in patients
being admitted with minimal thought for the
type of admission required.
In Phase 1, most referrers were external,
despite the busy community teams based at
the hospice. Most patients had a cancer
diagnosis rather than a non-cancer diagnosis
– the former traditionally attracting more
funding and resources. The hospice’s strategic
plan aimed to widen access to patients with
non-cancer diagnoses; therefore, a stronger
focus on these conditions was required. 
Respite care is often linked with a ‘crisis
intervention’ when the caring role breaks
down at home.18,24 Lack of planning leads to a
‘fire-fighting situation’ where emergency
support becomes necessary,10,25 which may
not be viewed as a ‘respite care’ intervention. 
In Phase 2, the pilot project provided an
opportunity for patients to benefit from the
input of a large multidisciplinary team and
enabled patients to remain at home for long
periods of time19,26,27 by providing their carers
with time off and thereby supporting them to
continue in their caring role.21,28,29
Respite is described as both a ‘service’
(depending on the setting) and an ‘outcome’
(relief from care-giving),12,24 where additional
therapies and interventions (such as
physiotherapy and occupational therapy) can
also be accessed.18,27 Patients who receive
respite care are generally not considered to be
medically complex; more emphasis is put on
rehabilitation and functionality. Flexibility (of
timing, frequency and activities) is considered
crucial.16 At the time of referral, patients were
thought to be medically stable and without
overwhelming symptom control problems;
therefore, their stay was suitable for
rehabilitation and a general overview.25,30
The fact that a date of discharge could be
predetermined possibly shows that patients
had been appropriately referred. No patients
died during respite care and this may be
indicative of referral criteria providing clarity
and a triage system ensuring patients are
appropriate for this type of admission. There
was a significantly higher proportion of
patients with non-malignant disease in
Phase 2. This widening of access is
encouraging; patients with long-term
progressive diseases that do not have such a
well-defined disease trajectory as cancer
frequently need ongoing support and breaks. 
There were a significant number of patients
who had no informal carers. The literature
suggests that respite care may be beneficial
with regard to keeping carers well and able to
continue in their role, especially as this
involves cost-savings for the health service,4
particularly towards the end of life,6 but there
has been minimal attention paid to, or studies
looking at, respite services for patients living
alone, despite this being acknowledged as an
area of increasing need.10,31
Kristjanson et al conducted a national
descriptive survey of patients and carers of
people with neurodegenerative conditions
using numerous assessment tools to identify
and compare the needs for supportive and
palliative care services.32 One finding was the
significant proportion of patients with
Table 2. Actual reason for admission 
(determined at initial assessment)
Respite 12 (44.5%)
Symptom control 10 (37.5%)
Terminal care 5 (18%)
People eligible for this service are:
• Patients who are medically stable
• Patients with a progressive and life-threatening
condition living at home
• Patients for whom the unpaid carers need a
break from caring
• Patients living at home alone who wish to 
have a break from care in this context
Priority will be given to:
• Patients who are thought to be in the last year 
of life. This can be determined by the patient
being on the Gold Standards Framework register
and asking other professionals caring for the
patient their opinion of prognosis
• Patients who are at risk of increasing levels of
dependency due to functional deterioration that
may be retrievable
Any other mitigating factors, such as burden of
illness, family and social factors, should be taken
into consideration
Box 1. Dedicated respite referral criteria
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multiple sclerosis who were living alone with
no carers at all. The benefits of receiving
respite care when living alone are to give
patients a break from the context of their
usual place of care, providing a holistic
assessment to review their care needs and
signposting them to ongoing alternative
support, such as befriending services and day
services. More work is required in this area.
There were several challenges in Phase 2.
The fact that the respite bed was in an ‘acute’
ward meant that the nursing staff needed to
adopt a change of mindset when caring for
respite patients. This was poorly achieved and,
on reflection, mixing two philosophies of care
was thought to be a cause of concern.
Although this was a nurse-led service, as the
respite patients were on an ‘acute’ ward, the
default position was to contact the ward
doctor to address any issues that could and
should have been managed by nurses. Finally,
respite patients found it difficult at times to
focus on rehabilitation and maximising
functionality, especially if they were in areas
where other patients may be dying. 
Respite care can be a poor relation to care
related to more complex needs, such as
symptom control; however, numerous
documents, including the End of Life Care
Strategy, refer to the importance of keeping
patients in their preferred place of care, which
frequently is their home. This may be more
readily achieved if patients and their carers
(when applicable) receive adequate support
and timely intervention to ensure that they
are able to stay at home for as long as possible. 
Future plans
A dedicated nurse-led respite unit with eight
beds has now opened at St Joseph’s Hospice,
which is widening access to all types of
conditions that are life-threatening and
progressive. Feedback from carers and patients
has been very positive. Formal evaluation
using a validated outcome measure
(St Christopher’s Index of Patient Priorities),
qualitative interviews and focus groups are
ongoing and involve patients, informal carers,
referrers and staff. 
In addition, further research is under way to
look at patients with neurodegenerative
diseases (as these patients and their carers
would benefit from, and require more access
to, respite care) and the role that a dedicated
respite care programme may play for them. 
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